1. Home
  2. NCI vs IMCC Comparison

NCI vs IMCC Comparison

Compare NCI & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCI
  • IMCC
  • Stock Information
  • Founded
  • NCI 1992
  • IMCC 1980
  • Country
  • NCI Hong Kong
  • IMCC Israel
  • Employees
  • NCI N/A
  • IMCC N/A
  • Industry
  • NCI
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • NCI
  • IMCC Health Care
  • Exchange
  • NCI NYSE
  • IMCC Nasdaq
  • Market Cap
  • NCI N/A
  • IMCC 4.4M
  • IPO Year
  • NCI 2024
  • IMCC N/A
  • Fundamental
  • Price
  • NCI $0.35
  • IMCC $1.70
  • Analyst Decision
  • NCI
  • IMCC
  • Analyst Count
  • NCI 0
  • IMCC 0
  • Target Price
  • NCI N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • NCI 99.7K
  • IMCC 10.4K
  • Earning Date
  • NCI 05-21-2025
  • IMCC 05-15-2025
  • Dividend Yield
  • NCI N/A
  • IMCC N/A
  • EPS Growth
  • NCI N/A
  • IMCC N/A
  • EPS
  • NCI 0.08
  • IMCC N/A
  • Revenue
  • NCI $22,481,862.00
  • IMCC $37,551,778.00
  • Revenue This Year
  • NCI N/A
  • IMCC $47.12
  • Revenue Next Year
  • NCI N/A
  • IMCC $12.83
  • P/E Ratio
  • NCI $4.17
  • IMCC N/A
  • Revenue Growth
  • NCI N/A
  • IMCC 10.71
  • 52 Week Low
  • NCI $0.28
  • IMCC $1.29
  • 52 Week High
  • NCI $1.80
  • IMCC $5.10
  • Technical
  • Relative Strength Index (RSI)
  • NCI N/A
  • IMCC 54.82
  • Support Level
  • NCI N/A
  • IMCC $1.56
  • Resistance Level
  • NCI N/A
  • IMCC $1.85
  • Average True Range (ATR)
  • NCI 0.00
  • IMCC 0.18
  • MACD
  • NCI 0.00
  • IMCC 0.04
  • Stochastic Oscillator
  • NCI 0.00
  • IMCC 70.69

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: